Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Orthogonal Trajectories01:26

Orthogonal Trajectories

49
Orthogonal trajectories describe the geometric relationship between two families of curves that intersect each other at right angles. One illustrative case involves a family of parabolas that open sideways along the x-axis. These curves share a common shape but differ by a scaling parameter, resulting in a set of curves that all pass through the origin and widen at different rates.Determining Orthogonal TrajectoriesTo identify the orthogonal trajectories for these parabolas, the first step...
49
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

223
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

181
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
181
What is Metabolism?00:52

What is Metabolism?

131.7K
Overview
131.7K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Clinical trials and evaluation of AI tools in solid organ transplantation: implications for clinical care, regulatory science, and rare diseases.

NPJ digital medicine·2026
Same author

Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.

Communications medicine·2026
Same author

Understanding the Mechanisms of Human Liver Regeneration via Characterization of Circulating Extracellular Vesicles.

BioMed research international·2026
Same author

Letter: Liver Transplantation Outcomes for Alcohol-Associated Liver Disease-Commentary on an Individual Patient Data Meta-Analysis and Future Research Directions. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
Same author

Impact of Diverse Clinical Characteristics on Survival Benefit of Liver Transplantation.

Journal of transplantation·2026
Same author

Topoisomerase IIb binding delineates localized mutational processes and driver mutations in cancer genomes.

Nature communications·2025

相关实验视频

Updated: Jan 31, 2026

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
10:04

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes

Published on: March 3, 2018

7.1K

预测代谢功能障碍相关型肝炎肝硬化患者的等待列表轨迹:一个神经网络竞争风险分析

Gopika Punchhi1,2, Yingji Sun2, Eunice Tan2,3,4

  • 1Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Journal of medical Internet research
|January 29, 2026
PubMed
概括

深度学习模型可以预测患有代谢功能障碍相关的脂肪肝肝硬化症患者的肝移植等候名单结果. 这种方法可以更好地预测移植和死亡风险,帮助临床决策.

关键词:
肝脏疾病 肝脏疾病肝硬化是肝硬化的一种疾病.深度学习是一种深度学习.肝脏疾病是一种肝脏疾病.肝脏移植 肝脏移植 肝脏移植 肝脏移植肝移植 肝移植 肝移植代谢功能障碍 代谢功能障碍与代谢功能障碍相关的脂肪肝炎.神经网络的神经网络的神经网络预测 预测 预测 预测预测性 预测性 预测性风险分析 风险分析等候名单的轨迹等待名单的轨迹

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

相关实验视频

Last Updated: Jan 31, 2026

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes
10:04

A Neural Network-Based Identification of Developmentally Competent or Incompetent Mouse Fully-Grown Oocytes

Published on: March 3, 2018

7.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 移植医学 移植医学
  • 医疗保健中的人工智能

背景情况:

  • 代谢功能障碍相关的脂肪肝炎 (MASH) 肝硬化是肝移植 (LT) 的主要驱动因素.
  • 目前的肝脏分配系统 (基于MELD) 在预测MASH患者等待名单死亡率方面存在局限性.
  • 现有的模型无法充分考虑等待名单上的死亡和LT的竞争风险.

研究的目的:

  • 开发和验证一个深度学习模型,用于预测MASH肝硬化患者的等候名单轨迹.
  • 将深度学习的预测性能与竞争风险的传统模型进行比较.
  • 为了确定影响肝移植等候名单患者结果的关键因素.

主要方法:

  • 一个深度学习竞争风险模型 (DeepHit) 是使用来自17551名MASH肝硬化患者的数据开发的.
  • 模型性能使用一致性指数,布里尔得分和一种新的竞争事件连贯性 (CEC) 评分来评估.
  • 进行了外部验证,特征重要性分析确定了关键预测变量.

主要成果:

  • DeepHit在多个时间点 (1-12个月) 预测竞争风险方面表现出优异的CEC分数.
  • 随机生存森林 (RSF) 显示死亡和移植的一致性指数较高,除了3个月死亡.
  • 确定MELD得分,功能状态,年龄和血型是等候名单结果的重要预测因素.

结论:

  • 深度学习竞争性风险分析为预测MASH患者的死亡和移植风险提供了强大的方法.
  • 这种方法可以通过突出关键的预后因素来加强临床决策.
  • 这项研究强调了人工智能在优化肝移植等候名单管理方面的潜力.